Detalles de la búsqueda
1.
ß-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer.
Transl Res;
260: 46-60, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37353110
2.
High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab.
Mol Cancer Res;
19(9): 1510-1521, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039647
3.
E7386, a Selective Inhibitor of the Interaction between ß-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Cancer Res;
81(4): 1052-1062, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408116
4.
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE study.
Breast Cancer;
27(4): 706-715, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32133606
5.
ß-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Mol Omics;
16(3): 195-209, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32203567
6.
Neuropilin-1 drives tumor-specific uptake of chlorotoxin.
Cell Commun Signal;
17(1): 67, 2019 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31208428
7.
Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades.
Biochem Biophys Res Commun;
513(1): 1-7, 2019 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30944079
8.
Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma.
Cancer Invest;
37(4-5): 185-198, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31006280
9.
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
PLoS One;
14(2): e0212513, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30811474
10.
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model.
Cancer Sci;
109(12): 3993-4002, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447042
11.
Short-Lived Radioisotope
Phys Rev Lett;
121(10): 102701, 2018 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30240253
12.
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms.
Anticancer Res;
38(6): 3375-3385, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848686
13.
Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
Cancer Res;
78(3): 817-829, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191802
14.
A hybrid type Ia supernova with an early flash triggered by helium-shell detonation.
Nature;
550(7674): 80-83, 2017 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28980637
15.
EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity.
Oncoimmunology;
6(8): e1338239, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28920002
16.
Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.
Cancer Res;
76(11): 3332-9, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27197173
17.
Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61.
Mol Cancer Ther;
15(6): 1208-16, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27196783
18.
The Dual MEK/FLT3 Inhibitor E6201 Exerts Cytotoxic Activity against Acute Myeloid Leukemia Cells Harboring Resistance-Conferring FLT3 Mutations.
Cancer Res;
76(6): 1528-37, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26822154
19.
[Advanced Digestive Cancer in Super Elderly Patients More Than 85 Years Old - Two Cases That Required Major Invasive Surgery].
Gan To Kagaku Ryoho;
43(12): 1538-1540, 2016 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-28133049
20.
E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.
Oncotarget;
6(38): 41307-23, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26513298